BCT — Briacell Therapeutics Share News
0.000.00%
Last trade - 00:00- CA$40.45m
- CA$7.65m
Brief: Briacell Adds Two Clinical Trial Sites To Accelerate Patient Enrollment
Brief: BriaCell To Uplist And Trade On Toronto Stock Exchange From TSX Venture Exchange Under 'BCT'; Remains 'BCTX' On Nasdaq
Brief: Briacell Announces Insiders' Intention To Purchase Up To 10% Of Public Market Securities
Brief: BriaCell Appoints Renowned Pharmaceutical Veteran Jane Gross To Its Board Of Directors
Brief: BriaCell Announces TSXV Acceptance Of Normal Course Issuer Bid
Brief: Briacell To Buy Back Up To 10% Of Common Shares, 10% Of Listed Warrants
Brief: Briacell Therapeutics Appoints Marc Lustig To Board Of Directors
U.S. STOCKS ON THE MOVE-Dlocal, Macy's, Robinhood, NLS Pharma, Ford, Sonoma Pharma
BriaCell gains on partnership with ImaginAb
Brief: Briacell And Imaginab Announce Collaboration To Evaluate Immunotherapy Imaging Technology In Advanced Breast Cancer
Brief: Briacell Therapeutics Says Will Voluntarily Delist Its Common Shares From Trading On Frankfurt Stock Exchange Effective August 19
Brief: Ault Global Holdings Inc Reports 6.15% Stake In Briacell Therapeutics Corp As Of August 6
U.S. STOCKS ON THE MOVE-BriaCell, Velodyne Lidar, Qualigen, Compass Minerals
BriaCell rises as co begins enrollment for breast cancer treatment trial
BriaCell Therapeutics: Jumps on expanding cancer drug pipeline
Brief: BriaCell Therapeutics Expands Breast Cancer Platform Technology Into Prostate, Melanoma, And Lung Cancers
Brief: Briacell Therapeutics Corp Files For Offering Of Up To 10.34 Million Common Shares By The Selling Shareholders - SEC Filing
BriaCell Therapeutics: Rises on $27.2 mln private placement
NASDAQ RESUMED AT 11:08 AM